FDA finalizes guidance on real-time review of oncology drugs
Regulatory NewsJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesBiotechnologyChemistry, Manufacturing and Controls (CMC)Clinical TrialsNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy